Global Stem Cell Assay Market

1 INTRODUCTION OF GLOBAL STEM CELL ASSAYMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL STEM CELL ASSAYMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL STEM CELL ASSAY MARKET, BY APPLICATION
5.1 Regenerative Medicine & Therapy Development
5.1.1 Orthopedic & Musculoskeletal Spine
5.1.2 Dermatology
5.1.3 Cardiovascular
5.1.4 Central Nervous System
5.1.5 Oncology
5.1.6 Diabetes
5.1.7 Others
5.2 Drug Discovery and Development
5.3 Clinical Research

6 GLOBAL STEM CELL ASSAY MARKET, BY PRODUCT
6.1 Instruments
6.1.1 Micro Electrode Arrays
6.1.2 Flow Cytometer
6.1.3 Cell Imaging Systems
6.1.4 Automated Cell Counter
6.2 Detection Kits
6.2.1 ImmunoHistochemistry Kits

7 GLOBAL STEM CELL ASSAY MARKET, BY END USER
7.1 Pharmaceutical & Biotechnology Companies
7.2 Research Institutes
7.3 Industry Research

8 GLOBAL STEM CELL ASSAY MARKET, BY TECHNOLOGY
8.1 Micro Fabricated Assisted Technology
8.1.1 Microfluidics Based Cell Trap Technologies

9 GLOBAL STEM CELL ASSAY MARKET, BY KITS
9.1 Adult Stem Cell Kits
9.1.1 Mesenchymal Stem Cell Kits
9.1.2 Induced Pluripotent Stem Cell Kits
9.1.3 Hematopoietic Stem Cell Kits
9.1.4 Neuronal Stem Cells Kits
9.1.5 Umbilical Cord Stem Cells
9.2 Human Embryonic Stem Cells Kits

10 GLOBAL STEM CELL ASSAY MARKET, BY ASSAY
10.1 Cell Viability & Toxicity Assays
10.2 Isolation/Purification Assays
10.3 Cell Identification Assays
10.4 Cell Proliferation Assays
10.5 Cell Differentiation Assays
10.6 Cell Function Assays
10.7 Cell Apoptosis Assays

11 GLOBAL STEM CELL ASSAYMARKET, BY GEOGRAPHY
11.1 Overview
11.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
11.2.1 U.S.
11.2.2 Canada
11.2.3 Mexico
11.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
11.3.1 Germany
11.3.2 U.K.
11.3.3 France
11.3.4 Rest of Europe
11.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 Rest of Asia Pacific
11.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
11.5.1 Brazil
11.5.2 Argentina
11.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

12 GLOBAL STEM CELL ASSAYMARKETCOMPETITIVE LANDSCAPE
12.1 Overview
12.2 Company Market Share
12.3 Vendor Landscape
12.4 Key Development Strategies

13 COMPANY PROFILES
13.1 GE Healthcare
13.1.1 Overview
13.1.2 Financial Performance
13.1.3 Product Outlook
13.1.4 Key Developments

13.2 Promega Corporation
13.2.1 Overview
13.2.2 Financial Performance
13.2.3 Product Outlook
13.2.4 Key Developments

13.3 Thermo Fisher Scientific Pvt. Ltd
13.3.1 Overview
13.3.2 Financial Performance
13.3.3 Product Outlook
13.3.4 Key Developments

13.4 Merck Millipore
13.4.1 Overview
13.4.2 Financial Performance
13.4.3 Product Outlook
13.4.4 Key Developments

13.5 Cell Bio Labs, Inc.
13.5.1 Overview
13.5.2 Financial Performance
13.5.3 Product Outlook
13.5.4 Key Developments

13.6 Hemogenix Inc.
13.6.1 Overview
13.6.2 Financial Performance
13.6.3 Product Outlook
13.6.4 Key Developments

13.7 Stem Cell Technologies
13.7.1 Overview
13.7.2 Financial Performance
13.7.3 Product Outlook
13.7.4 Key Developments

13.8 Bio Rad
13.8.1 Overview
13.8.2 Financial Performance
13.8.3 Product Outlook
13.8.4 Key Developments

13.9 R&D Systems
13.9.1 Overview
13.9.2 Financial Performance
13.9.3 Product Outlook
13.9.4 Key Development

13.10 Cellular Dynamics International.
13.10.1 Overview
13.10.2 Financial Performance
13.10.3 Product Outlook
13.10.4 Key Development

14 Appendix
14.1 Related Reports